08/14/2025
10:54 AM | Aligos Therapeutics (Subject)
Woodline Partners LP (Filed by)
| Form SCHEDULE 13G/A | |
08/13/2025
1:00 PM | Aligos Therapeutics (Subject)
Sio Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
08/12/2025
8:00 AM | Adage Capital Management, L.P. (Filed by)
Aligos Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/06/2025
3:36 PM | Aligos Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/18/2025
4:14 PM | Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2025
4:14 PM | Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2025
3:41 PM | Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:29 PM | Aligos Therapeutics (Issuer)
Martell Bridget A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:29 PM | Aligos Therapeutics (Issuer)
Chavez Margarita (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:30 PM | Aligos Therapeutics (Issuer)
Preston Heather (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:30 PM | Aligos Therapeutics (Issuer)
Hirth Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ALGS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/26/2025
3:30 PM | Aligos Therapeutics (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:31 PM | Aligos Therapeutics (Issuer)
Nuechterlein Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
3:09 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
12:53 PM | Aligos Therapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/15/2025
8:33 AM | Aligos Therapeutics (Subject)
Woodline Partners LP (Filed by)
| Form SCHEDULE 13G | |
05/06/2025
7:14 AM | Aligos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2025
7:00 AM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
3:12 PM | Aligos Therapeutics (Filer)
| Form ARS | |
04/28/2025
3:15 PM | Aligos Therapeutics (Filer)
| Form DEFA14A | |
04/03/2025
11:15 PM | Aligos Therapeutics (Filer)
| Form EFFECT | |
04/03/2025
3:23 PM | Aligos Therapeutics (Filer)
| Form 424B3 | |
03/12/2025
7:30 PM | Aligos Therapeutics (Subject)
BLATT LAWRENCE (Filed by)
| Form SCHEDULE 13D/A | |
03/10/2025
7:00 AM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2025
7:07 AM | Aligos Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2025
8:32 AM | Adage Capital Management, L.P. (Filed by)
Aligos Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
7:52 AM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
3:02 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
11:15 PM | Aligos Therapeutics (Filer)
| Form EFFECT | |
11/14/2024
5:57 PM | Aligos Therapeutics (Subject)
Vivo Capital Fund VIII, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
5:19 PM | Aligos Therapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
3:34 PM | Aligos Therapeutics (Subject)
HHLR ADVISORS, LTD. (Filed by)
| Form SC 13G/A | |
11/12/2024
8:31 AM | Adage Capital Management, L.P. (Filed by)
Aligos Therapeutics (Subject)
| Form SC 13G | |
11/06/2024
4:20 PM | Aligos Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/06/2024
4:14 PM | Aligos Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/06/2024
3:24 PM | Aligos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
3:05 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
3:16 PM | Achneck Hardean (Reporting)
Aligos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2024
3:15 PM | Achneck Hardean (Reporting)
Aligos Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2024
3:22 PM | Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
3:23 PM | Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Former CIA Officer Reveals How Gold Saved His Life (Ad)
This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained to stay alive when systems collapse.
In Operation Gold Rush, Jason Hanson reveals how gold and silver saved his life—and how they could protect yours in the next crisis. You’ll learn how to hide gold like a covert operative, secure your 401(k) in physical assets, and prepare for grid failures, economic collapse, or worse. Click here to get your free copy + up to $10,000 in free silver while supplies last. |
09/06/2024
3:23 PM | Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:06 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
3:05 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access